The European Commission (EC) has published a Brexit Readiness Checklist in anticipation of the end of the transition period on 1 January 2021. Read more “‘Brexit Readiness Checklist’ for companies doing business with the UK”
Category: Industry news
The latest news from the Pharmaceutical Industry
Stockpiling drugs in anticipation of the end of Brexit Transition
The UK government has written an open letter to medicine suppliers, outlining how supply can be maintained in anticipation of the end the Brexit transition period on 31 December 2020. Read more “Stockpiling drugs in anticipation of the end of Brexit Transition”
Highlights from the July CHMP meeting 2020
From their meeting in July, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has published the highlights. Read more “Highlights from the July CHMP meeting 2020”
Find out about the latest MDR implementation updates
The European Commission (EC) have recently provided several updates on the implementation of the Medical Device Regulation (MDR). Read more “Find out about the latest MDR implementation updates”
Did you know that the EMA have a new Executive Director?
The European Medicines Agency (EMA) have nominated Emer Cooke as their new Executive Director. Read more “Did you know that the EMA have a new Executive Director?”
Highlights from the April CHMP meeting 2020
From their meeting in April, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has published the highlights. Read more “Highlights from the April CHMP meeting 2020”
Highlights from the March CHMP meeting 2020
From their meeting in March, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has published the highlights. Read more “Highlights from the March CHMP meeting 2020”
Further information on how to manage clinical trials during the pandemic
The Medicines and Healthcare products Regulatory Agency (MHRA) have now released guidance on how investigators and sponsors should manage clinical trials during COVID-19. Read more “Further information on how to manage clinical trials during the pandemic”
Coronavirus-induced drug and device shortages
As the novel coronavirus outbreak continues to spread across the globe, Europe and the US are bracing for disruption to the medicine supply chain. Read more “Coronavirus-induced drug and device shortages”
Brexit done: more information on the regulatory challenges that await
After years of waiting and wondering, the UK has finally left the EU. So, in the short term, how will the regulatory and drug safety environment change, and what will stay the same?
Read more “Brexit done: more information on the regulatory challenges that await”